Viral host-pathogen interactions and developing subunit vaccines and antivirals are what we love. Led by @NUSMedAlonsoS. Tweets by lab members!
Singapore
Joined April 2023
- Tweets55
- Following90
- Followers116
- Likes10
The dengue team at #HCVFlavi2025. A conference with amazing people and great science!
Hot from the press! Fakhri’s paper on the importance of glycans on DENV NS1 is out!
Read more here embopress.org/doi/full/10.10…
it’s @NUSMedAlonsoS birthday 🎉🎉confetti for the aesthetic shot but note to self, don’t do it on a carpeted floor!
Our first hangout with @VignuzziLab, was a great exchange of knowledge and expertise!
Sylvie Alonso’s Group retweeted
1/ Increasing vaccine protection against #COVID. A/Prof @SAlonsoGroup @NUSingapore & A/Prof @LahoudMirei @MonashBDI have discovered a technique for prolonging immune response to #SARSCoV2 virus in pre-clinical models using an antibody construct. More: bit.ly/3yKN3Ek
ALT L-R: Associate Professors Sylvia Alonso (NUS) and Mireille Lahoud (Monash BDI), senior authors on the Molecular Therapy paper, Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice.
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity.
A fantastic collaboration between @MonashBDI and @NUSingapore.
doi.org/10.1016/j.ymthe.2024…
Sylvie Alonso’s Group retweeted
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity.
A fantastic collaboration between @MonashBDI and @NUSingapore.
doi.org/10.1016/j.ymthe.2024…
The Clec9A team at APVIC! It was a great conference with many insightful talks by distinguished speakers :)
Sylvie Alonso’s Group retweeted
📢Don't miss our BDI seminar this Fri 17 May, 12-1pm!
𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso @SAlonsoGroup @nusingapore
𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases
bit.ly/3uCUMgc
ALT 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso @SAlonsoGroup @nusingapore 𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases 𝗪𝗵𝗲𝗻: Fri 17 May 12-1pm
Featuring our new publication on @MolTherapy deeply characterizing a cDC1 targeting vaxx strategy we have focused on for years, this time in SARS-CoV-2 context. Overall, our findings present its promise as a next gen pandemic response vaxx strategy Congrats to @_immunogeNIC agn!
Proudly sharing that the 1st phase of my PhD work is officially published! Here, we characterized the immune response elicited by a Clec9A-cDC1 targeting SARS-CoV-2 vaccine. Thankful for @NUSMedAlonsoS guidance and all coauthors' contributions! See below our summarized findings.
happy lunar new year from SA lab!! wishing everyone a healthy and prosperous (publications and grants 😌) year ahead
thank you for such an insightful talk!!
This Post is from an account that no longer exists. Learn more
thanks for giving such a great talk!!!#longliveIVBDC
Had an engaging week at the #IVBDC2023: Shared our work on mosquito reproduction & population genomics; Was inspired by cool science & emerging technology in vector control; Had fun catching up with ex-students! Big 🙏🏾 to @SAlonsoGroup & @NUS_DBS
so nice to see you again @AngTopher!!!! till the next conference :)
2 presentations in a month, this time round at #IVBDC23. @NUSMedAlonsoS presenting the recent work on DENV NS1 done by Dr Fakhri :)
Featuring the boss @NUSMedAlonsoS presenting a translational and exciting story about the lab's cDC1 targeting vaccine research at the annual SgSI symposium. 🎉🎉🎉
